Community Oncology Alliance shared on LinkedIn:
“COA’s Executive Director Ted Okon is testifying Now before the House Oversight Committee on the factors driving unaffordable oral chemotherapy.
He’s highlighting the role that ‘fail-first’ step therapy, burdensome prior authorization, and incomplete coverage of oral drugs plays in limiting patient access to critical therapies.
Other posts about Community Oncology Alliance on OncoDaily.